Cross-Cultural Adaptation and Psychometric Validation of the Turkish Version of Atroshi-Lyrén 6-item Symptoms Scale

NCT ID: NCT05970692

Last Updated: 2024-02-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-09-26

Study Completion Date

2024-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to develop Turkish version of the Atroshi-Lyrén 6-item symptoms scale (A-L scale) and to perform validity and reliability evaluations.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Carpal Tunnel Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Healthy Controls

Healthy individuals aged between 18-65 years old

No interventions assigned to this group

CTS Group

CTS patients aged between 18-65 years old

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Aged between 18-65 years old,
* Had symptoms of numbness, tingling, weakness and pain in the hands for at least 1 month,
* Assessed through provocation tests and physical examination to match the median nerve distribution.

Exclusion Criteria

* Not willing to participate in the study,
* Clinical or electrophysiological signs of proximal nerve compression,
* Diabetes or other metabolic disease,
* Rheumatoid arthritis or other general inflammatory diseases.
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Bitlis Eren University

OTHER

Sponsor Role collaborator

Ilke KARA

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ilke KARA

Co-Principal Investigator

Responsibility Role SPONSOR_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Bitlis Eren University

Bitlis, , Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Tülay Çevik Saldıran, PhD

Role: CONTACT

+90 (434) 222 83 32

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Tülay Çevik Saldıran, PhD

Role: primary

+90 (434) 222 83 32

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

BEU-KTS-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Scale Development Study
NCT06695390 COMPLETED
TEMPS-A and Menopause Symptoms
NCT06972290 COMPLETED